|
|
Volumn 27, Issue 3, 2009, Pages 222-225
|
|
Fresh from the biologic pipeline
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACCRETROPIN;
ADALIMUMAB;
ALVIMOPAN;
BANZEL;
BENDAMUSTINE;
CELECOXIB;
CERTOLIZUMAB PEGOL;
CINRYZE;
COMPLEMENT COMPONENT C1S INHIBITOR;
ELTROMBOPAG;
ETORICOXIB;
FABLYN;
FOSPROPOFOL;
GABAPENTIN;
HUMAN GROWTH HORMONE;
INFLIXIMAB;
LAMOTRIGINE;
LASOFOXIFENE;
LEXISCAN;
LUSEDRA;
NATALIZUMAB;
NONSTEROID ANTIINFLAMMATORY AGENT;
NPLATE;
PAROXETINE;
PLERIXAFOR;
PREGABALIN;
RALOXIFENE;
RECOMTHRON;
REGADENOSON;
RILONACEPT;
ROFECOXIB;
ROMIPLOSTIM;
ROSIGLITAZONE;
ROTAVIRUS VACCINE;
RUFINAMIDE;
THROMBIN;
TOPIRAMATE;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
ANGIONEUROTIC EDEMA;
BLEEDING;
CANCER RISK;
CARDIOVASCULAR RISK;
CHEMOPROPHYLAXIS;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL TRIAL;
CROHN DISEASE;
DEPRESSION;
DIABETES MELLITUS;
DRUG APPROVAL;
DRUG FORMULATION;
DRUG MARKETING;
DRUG MONITORING;
DRUG SAFETY;
ENDOMETRIUM CANCER;
EPILEPSY;
FOOD AND DRUG ADMINISTRATION;
GOUT;
GROWTH DISORDER;
HEART INFARCTION;
HUMAN;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
ILEUS;
LENNOX GASTAUT SYNDROME;
LYMPHOMA;
MALIGNANT NEOPLASTIC DISEASE;
MULTIPLE SCLEROSIS;
NONHODGKIN LYMPHOMA;
NOTE;
PAIN;
PANIC;
POSTMENOPAUSE OSTEOPOROSIS;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RETINA MACULA AGE RELATED DEGENERATION;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
SEIZURE;
SIDE EFFECT;
STEM CELL MOBILIZATION;
STROKE;
SUICIDAL IDEATION;
THROMBOCYTOPENIA;
VAGINA ATROPHY;
VIRAL GASTROENTERITIS;
BIOTECHNOLOGY;
CARRIER PROTEINS;
COMPLEMENT C1 INACTIVATOR PROTEINS;
DRUG APPROVAL;
DRUG TOXICITY;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
POLYETHYLENE GLYCOLS;
RECEPTORS, FC;
RECOMBINANT FUSION PROTEINS;
RECOMBINANT PROTEINS;
ROTAVIRUS VACCINES;
THROMBIN;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VACCINES, ATTENUATED;
|
|
EID: 62149141200
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0309-222 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
